2023-07-20 18:21:39
Worldwide, more than 334 million people have asthma. This is considered a public health problem present in all countries, regardless of their level of development and that affects all age groups.
In many countries the prevalence of asthma is increasing, especially among children. In Mexico, it affects less than 7% of the population and is among the top 20 causes of disease and one of the top 10 causes of care in emergency and outpatient services, due to the lack of diagnosis and adequate control.
Asthma figures importantly in public health
The World Health Organization (WHO) recognizes that asthma figures importantly in public health. However, it is less diagnosed and treated than it should be. In some countries, they have seen a decline in hospitalizations and deaths from asthma, this places a burden on health care systems and on society through lost productivity in the workplace. In the case of pediatric asthma, the disruption of family life.
Evolution of treatment is based on better knowledge
The evolution of asthma treatment is based on a better understanding of the disease, to keep it under control and reduce the risks by avoiding excessive use of rescue medications. It is important to mention that pharmacological treatment is not the only way to control asthma, being a key factor in education about this condition in order to avoid its triggers.
Dr. Alberto Hegewisch, Medical Director of AstraZeneca Mexico, explained that “at AstraZeneca, we follow science to bring innovative therapies that can help people better manage their disease and thereby improve the quality of life of Mexicans. We continually work to discover and understand the complexities of asthma, supported by AstraZeneca’s legacy in Respiratory and Immunology.”
#approach #asthma #Mexico #changed #years